Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) Short Interest Down 91.3% in August

Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) was the recipient of a large drop in short interest in August. As of August 14th, there was short interest totaling 140 shares, a drop of 91.3% from the July 30th total of 1,608 shares. Based on an average trading volume of 1,984 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the shares of the stock are short sold.

Mosaic ImmunoEngineering Price Performance

Shares of OTCMKTS CPMV opened at $0.06 on Thursday. Mosaic ImmunoEngineering has a 12-month low of $0.05 and a 12-month high of $1.05. The company has a market capitalization of $441,640.00, a PE ratio of -0.68 and a beta of -0.82. The firm’s 50-day moving average is $0.48 and its two-hundred day moving average is $0.57.

Mosaic ImmunoEngineering (OTCMKTS:CPMV) last issued its quarterly earnings data on Friday, August 14th. The company reported ($0.02) earnings per share for the quarter.

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering (OTCMKTS:CPMV) is a development-stage biotechnology company focused on advancing immunotherapies and vaccine candidates through its proprietary nanoparticle platform. The company leverages virus-like particles derived from the cowpea mosaic virus (CPMV) to serve as both antigen carriers and immune stimulators, aiming to enhance the magnitude and durability of immune responses. By engineering these plant-based VLPs to display target antigens or adjuvant properties, Mosaic ImmunoEngineering seeks to create differentiated candidates for oncology indications and infectious disease prevention.

Operating out of the United States, Mosaic ImmunoEngineering is currently in preclinical stages of development.